The crystal structure of bromide-bound GtACR1 reveals a pre-activated state in the transmembrane anion tunnel

  1. Hai Li
  2. Chia-Ying Huang
  3. Elena G Govorunova
  4. Oleg A Sineshchekov
  5. Adrian Yi
  6. Kenneth J Rothschild
  7. Meitian Wang
  8. Lei Zheng  Is a corresponding author
  9. John L Spudich  Is a corresponding author
  1. University of Texas Health Science Center at Houston, McGovern Medical School, United States
  2. Swiss Light Source, Paul Scherrer Institute, Switzerland
  3. Boston University, United States

Abstract

The crystal structure of the light-gated anion channel GtACR1 reported in our previous Research Article (Li et al., 2019) revealed a continuous tunnel traversing the protein from extracellular to intracellular pores. We proposed the tunnel as the conductance channel closed by three constrictions: C1 in the extracellular half, mid-membrane C2 containing the photoactive site, and C3 on the cytoplasmic side. Reported here, the crystal structure of bromide-bound GtACR1 reveals structural changes that relax the C1 and C3 constrictions, including a novel salt-bridge switch mechanism involving C1 and the photoactive site. These findings indicate that substrate binding induces a transition from an inactivated state to a pre-activated state in the dark that facilitates channel opening by reducing free energy in the tunnel constrictions. The results provide direct evidence that the tunnel is the closed form of the channel of GtACR1 and shed light on the light-gated channel activation mechanism.

Data availability

Diffraction data have been deposited in PDB under the accession code 7L1E.

The following data sets were generated

Article and author information

Author details

  1. Hai Li

    Department of Biochemistry and Molecular Biology, McGovern Medical School, University of Texas Health Science Center at Houston, McGovern Medical School, Houston, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-3969-6709
  2. Chia-Ying Huang

    Macromolecular Crystallography, Swiss Light Source, Paul Scherrer Institute, Villigen, Switzerland
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-7676-0239
  3. Elena G Govorunova

    Center for Membrane Biology, Department of Biochemistry and Molecular Biology, University of Texas Health Science Center at Houston, McGovern Medical School, Houston, United States
    Competing interests
    Elena G Govorunova, as an inventor and The University of Texas Health Science Center at Houston has been granted a patent titled: Compositions and Methods for Use of Anion Channel Rhodopsins Patent # 10,519,205 granted Dec 31, 2019 by the US Patent and Trademark Office..
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-0522-9683
  4. Oleg A Sineshchekov

    Center for Membrane Biology, Department of Biochemistry and Molecular Biology, University of Texas Health Science Center at Houston, McGovern Medical School, Houston, United States
    Competing interests
    Oleg A Sineshchekov, as an inventor and The University of Texas Health Science Center at Houston has been granted a patent titled: Compositions and Methods for Use of Anion Channel Rhodopsins Patent # 10,519,205 granted Dec 31, 2019 by the US Patent and Trademark Office..
  5. Adrian Yi

    Boston University, Boston, United States
    Competing interests
    No competing interests declared.
  6. Kenneth J Rothschild

    Boston University, Boston, United States
    Competing interests
    No competing interests declared.
  7. Meitian Wang

    Macromolecular Crystallography, Swiss Light Source, Paul Scherrer Institute, Villigen, Switzerland
    Competing interests
    No competing interests declared.
  8. Lei Zheng

    Center for Membrane Biology, Department of Biochemistry and Molecular Biology, University of Texas Health Science Center at Houston, McGovern Medical School, Houston, United States
    For correspondence
    Lei.Zheng@uth.tmc.edu
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-7789-5234
  9. John L Spudich

    Center for Membrane Biology, Department of Biochemistry and Molecular Biology, University of Texas Health Science Center at Houston, McGovern Medical School, Houston, United States
    For correspondence
    John.L.Spudich@uth.tmc.edu
    Competing interests
    John L Spudich, as an inventor and The University of Texas Health Science Center at Houston has been granted a patent titled: Compositions and Methods for Use of Anion Channel Rhodopsins Patent # 10,519,205 granted Dec 31, 2019 by the US Patent and Trademark Office..
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-4167-8590

Funding

National Institute of General Medical Sciences (R01GM027750)

  • John L Spudich

National Institute of General Medical Sciences (R35GM140838)

  • John L Spudich

Robert A. Welch Foundation (Endowed Chair AU-0009)

  • John L Spudich

American Heart Association (18TPA34230046)

  • Lei Zheng

National Science Foundation (CBET-1264434)

  • Kenneth J Rothschild

European Union's Horizon 2020 (Marie-Skłodowska-Curie grant agreement No. 701647)

  • Chia-Ying Huang

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2021, Li et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,213
    views
  • 179
    downloads
  • 10
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Hai Li
  2. Chia-Ying Huang
  3. Elena G Govorunova
  4. Oleg A Sineshchekov
  5. Adrian Yi
  6. Kenneth J Rothschild
  7. Meitian Wang
  8. Lei Zheng
  9. John L Spudich
(2021)
The crystal structure of bromide-bound GtACR1 reveals a pre-activated state in the transmembrane anion tunnel
eLife 10:e65903.
https://doi.org/10.7554/eLife.65903

Share this article

https://doi.org/10.7554/eLife.65903

Further reading

    1. Structural Biology and Molecular Biophysics
    Liliana R Teixeira, Radha Akella ... Elizabeth J Goldsmith
    Research Article

    Osmotic stress and chloride regulate the autophosphorylation and activity of the WNK1 and WNK3 kinase domains. The kinase domain of unphosphorylated WNK1 (uWNK1) is an asymmetric dimer possessing water molecules conserved in multiple uWNK1 crystal structures. Conserved waters are present in two networks, referred to here as conserved water networks 1 and 2 (CWN1 and CWN2). Here, we show that PEG400 applied to crystals of dimeric uWNK1 induces de-dimerization. Both the WNK1 the water networks and the chloride-binding site are disrupted by PEG400. CWN1 is surrounded by a cluster of pan-WNK-conserved charged residues. Here, we mutagenized these charges in WNK3, a highly active WNK isoform kinase domain, and WNK1, the isoform best studied crystallographically. Mutation of E314 in the Activation Loop of WNK3 (WNK3/E314Q and WNK3/E314A, and the homologous WNK1/E388A) enhanced the rate of autophosphorylation, and reduced chloride sensitivity. Other WNK3 mutants reduced the rate of autophosphorylation activity coupled with greater chloride sensitivity than wild-type. The water and chloride regulation thus appear linked. The lower activity of some mutants may reflect effects on catalysis. Crystallography showed that activating mutants introduced conformational changes in similar parts of the structure to those induced by PEG400. WNK activating mutations and crystallography support a role for CWN1 in WNK inhibition consistent with water functioning as an allosteric ligand.

    1. Structural Biology and Molecular Biophysics
    Jinsai Shang, Douglas J Kojetin
    Research Advance

    Peroxisome proliferator-activated receptor gamma (PPARγ) is a nuclear receptor transcription factor that regulates gene expression programs in response to ligand binding. Endogenous and synthetic ligands, including covalent antagonist inhibitors GW9662 and T0070907, are thought to compete for the orthosteric pocket in the ligand-binding domain (LBD). However, we previously showed that synthetic PPARγ ligands can cooperatively cobind with and reposition a bound endogenous orthosteric ligand to an alternate site, synergistically regulating PPARγ structure and function (Shang et al., 2018). Here, we reveal the structural mechanism of cobinding between a synthetic covalent antagonist inhibitor with other synthetic ligands. Biochemical and NMR data show that covalent inhibitors weaken—but do not prevent—the binding of other ligands via an allosteric mechanism, rather than direct ligand clashing, by shifting the LBD ensemble toward a transcriptionally repressive conformation, which structurally clashes with orthosteric ligand binding. Crystal structures reveal different cobinding mechanisms including alternate site binding to unexpectedly adopting an orthosteric binding mode by altering the covalent inhibitor binding pose. Our findings highlight the significant flexibility of the PPARγ orthosteric pocket, its ability to accommodate multiple ligands, and demonstrate that GW9662 and T0070907 should not be used as chemical tools to inhibit ligand binding to PPARγ.